title: Membrane fluidity and lipid composition in clinical isolates of Candida albicans isolated from AIDS/HIV patients.
abstract: In this study, we describe the membrane lipid composition of eight clinical isolates (azole resistant and sensitive strains) of Candida albicans isolated from AIDS/ HIV patients. Interestingly, fluorescence polarization measurements of the clinical isolates displayed enhanced membrane fluidity in fluconazole resistant strains as compared to the sensitive ones. The increase in fluidity was reflected in the change of membrane order, which was considerably decreased (decrease in fluorescence polarization "p" value denotes higher membrane fluidity) in the resistant strains. The ergosterol content in azole susceptible isolates was greater, almost twice as compared to the resistant isolates. However, no significant alteration was observed in phospholipid and fatty acid composition of these isolates. Labeling experiments with fluorescamine dye revealed that the percentage of phosphatidylethanolamine exposed to the membrane's outer leaflet was higher in the resistant strains as compared to the sensitive strains, indicating increased floppase activity of the two major ABC drug efflux pumps, CDR1 and CDR2 possibly due to their overexpression in resistant strains. The results of the present study suggest that changes in the status of membrane lipid phase especially the ergosterol content and increased activity of drug efflux pumps by overexpression ofABC transporters, CDR1 and CDR2 might contribute to fluconazole resistance in C. albicans isolated from AIDS/HIV patients.
authors: Department of Biochemistry, University of Allahabad, Allahabad-211002, India. nagendranathmishra@yahoo.co.in
authors: N N
authors: NN
authors: Mishra
authors: T
authors: T
authors: Prasad
authors: N
authors: N
authors: Sharma
authors: Ali Abdul
authors: AA
authors: Lattif
authors: R
authors: R
authors: Prasad
authors: D K
authors: DK
authors: Gupta
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000382:microbiology*; D002176:Candida albicans / Q000737:chemistry* / Q000187:drug effects; D025141:Drug Resistance, Fungal; D004875:Ergosterol / Q000032:analysis; D015658:HIV Infections / Q000382:microbiology*; D006801:Humans; D008560:Membrane Fluidity; D008563:Membrane Lipids / Q000032:analysis*
chemical_list: D008563:Membrane Lipids; D004875:Ergosterol